News
Kent State Maintains Prestigious R1 Research Activity Designation With 2025 Carnegie Classifications
With the release of the new 2025 Carnegie Classification of Institutions of Higher Education, Kent State University has once again been awarded the prestigious R1 designation, recognizing Kent State as one of the top research universities in the nation.
Kent State University’s Neurodiversity Research Initiative has partnered with the Pontifical Catholic University of Paraná (PUCPR), for a three-day seminar on autism research.
In Assistant Professor Michelle Bebber's class, students learn how prehistoric people hunted for food and learn to use the ancient weapons they used.
A groundbreaking phase one clinical trial exploring a novel cell-based immunotherapy for breast cancer has been accepted for publication in JAMA Oncology. The technology tested in the trial was co-developed by Gary Koski, Ph.D., professor in Kent State University’s Department of Biological Sciences, and Brian J. Czerniecki, M.D., Ph.D., chair and senior member in the Moffitt Cancer Center’s Department of Breast Oncology.
A group of high school students from Cleveland visited campus as part of a grant-funded program designed to showcase STEM education opportunities in robotics and computer science.